Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Daiichi Sankyo's AFib Tablets Gain FDA Approval

January 9, 2015 9:36 am | News | Comments

The tablets reduce the risk of stroke and systemic embolism. Read more...                               

TOPICS:

Bacteria May Contribute to Wound-Induced Skin Cancer

January 9, 2015 9:24 am | by King's College London | News | Comments

Researchers have identified a new mechanism by which skin damage triggers the formation of tumors. Read more...                         

TOPICS:

FDA Approves Roche's HIV, Hepatitis Screening Test

January 9, 2015 9:09 am | News | Comments

The combination of viral target detection and identification steps on a fully automated system offers workflow advantages to blood and plasma testing centers. Read more...               

TOPICS:
Advertisement

Cipher Pharmaceuticals Acquires Melanovus Oncology Assets

January 9, 2015 9:02 am | News | Comments

The transaction includes an upfront payment to Melanovus of 500,000, as well as the payment of certain IP expenses related to patent prosecution and maintenance. Read more...             

TOPICS:

New Bioanalytical Technology Holds Promise for Alzheimer’s Research

January 9, 2015 9:00 am | by Stephen Turner, CEO, Protea Biosciences Group Inc.; Roxana Carare, MD, PhD., University of Southampton, and Peggi M. Angel, PhD., Senior Scientist, LAESI Mass Spectrometry Imaging, Protea Biosciences Group Inc. | Articles | Comments

Alzheimer's disease (AD) is a progressive, neurodegenerative disorder that is the leading cause of dementia in the elderly (60%), affecting 13% to 20% of people over the age of 65 years. Read more...                                 

TOPICS:

2 Leading Ebola Vaccines Appear Safe, Further Tests Starting

January 9, 2015 8:51 am | by Maria Cheng - AP Medical Writer | News | Comments

The World Health Organization said the two leading Ebola vaccines appear safe and will soon be tested in healthy volunteers in West Africa. Read more...                  

TOPICS:

The Battle Brewing Over Hepatitis C Drugs

January 8, 2015 3:05 pm | by Ryan Bushey, Associate Editor | Articles | Comments

Abbvie and Gilead are fighting for control over this lucrative drug market. Read more...                            

TOPICS:

23andMe, Genentech Team Up for Research Project on Parkinson's Disease

January 8, 2015 2:03 pm | News | Comments

23andMe and Genentech will together to generate whole genome sequencing data for approximately 3,000 people in 23andMe's Parkinson's disease community. Read more...              

TOPICS:
Advertisement

Pfizer's New Cancer Drug May Get Early Approval

January 8, 2015 1:27 pm | by Linda A. Johnson - AP Business Writer | News | Comments

Analysts believe Pfizer's new cancer drug appears poised for approval within a few months and could be a new blockbuster. Read more...                    

TOPICS:

'Cellular Backpacks' Attach to White Blood Cells Targeting Inflammation

January 8, 2015 12:52 pm | by University of California, Santa Barbara | News | Comments

Persistent inflammation is often indicative of more serious conditions and can lead to problems of its own, including impaired healing, loss of function or even tissue death. Read more...            

TOPICS:

Broad Immune Response May Destroy Latent HIV

January 8, 2015 12:39 pm | by Yale University | News | Comments

A major barrier to finding a cure for HIV/AIDS is the presence of latent HIV in the cells of chronically infected individuals. Read more...                    

TOPICS:

Major Breakthrough in Reducing Cost of Key AIDS Drug

January 8, 2015 12:20 pm | by VCU | News | Comments

A team of researchers has invented a far more cost-effective way to manufacture a widely used AIDS drug. Read more...                        

TOPICS:

Pharming and Salix: HAE Trial's First Patient Treated

January 8, 2015 10:26 am | by Ruconest | News | Comments

Pharming Group NV and Salix Pharmaceuticals, Ltd. announced that the first patient was treated in their Phase 2 clinical study of Ruconest, (C1 Esterase Inhibitor [Recombinant]) 50 IU/kg, for prophylaxis in patients with hereditary angioedema (HAE).  Read more...

TOPICS:

Vatican Earmarks $3.55 Million for Ebola Care

January 8, 2015 10:21 am | by Associated Press | News | Comments

The Vatican is increasing assistance to Western African countries hard-hit by the Ebola virus, setting aside 3 million euros ($3.55 million) to fund protective gear for care-givers, transport for sick patients and care for orphans left behind. 

TOPICS:

Snail Venom Sting in Tail of Cancer, Addiction

January 8, 2015 10:16 am | by University of Queensland | News | Comments

Cone snail venom has given University of Queensland researchers a lead on the possible detection and treatment of some cancers and addictions. Read more...                                  

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading